Literature DB >> 35530654

Impact of Hippocampal Avoidance - Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients.

Emmanouil Maragkoudakis1, Vasileios Kouloulias1, Maria Grenzelia2, Andromachi Kougioumtzopoulou1, Anna Zygogianni2, Vasileios Ramfidis3, Andrianni Charpidou3.   

Abstract

BACKGROUND/AIM: Prophylactic cranial irradiation (PCI) is a well-established treatment of small cell lung cancer (SCLC) patients following response to initial chemoradiotherapy. The benefit of PCI does, however, come at the cost of cognitive decline. This has been attributed to radiation-induced toxicity at the hippocampus, a crucial anatomic area for cognition. Modern radiotherapy techniques allow dose reduction at the hippocampal region. In this review, the safety profile, effect on cognition, and changes on brain imaging modalities of hippocampal avoidance-PCI (HA-PCI) will be presented, aiming to identify a potential clinical rationale for SCLC patients.
MATERIALS AND METHODS: A systematic review of the literature was performed in Pubmed, Cochrane library databases and ClinicalTrials.gov with no past date limitations until 07/01/2022. Principles as outlined in the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement were followed.
RESULTS: Eight studies published from 2015 to 2021 were included.
CONCLUSION: HA-PCI is safe, yet its effect on neurocognition and imaging remains unclear, as studies have shown contradictory results. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Prophylactic cranial irradiation; hippocampal avoidance; neurocognition; review; small cell lung cancer

Year:  2022        PMID: 35530654      PMCID: PMC9066538          DOI: 10.21873/cdp.10105

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  24 in total

1.  Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging.

Authors:  Chukwuka Eze; Olarn Roengvoraphoj; Maximilian Niyazi; Guido Hildebrandt; Rainer Fietkau; Claus Belka; Farkhad Manapov
Journal:  Clin Lung Cancer       Date:  2016-11-21       Impact factor: 4.785

Review 2.  Memory function and the hippocampus.

Authors:  Bertram Opitz
Journal:  Front Neurol Neurosci       Date:  2014-04-16

3.  Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.

Authors:  Vinai Gondi; Stephanie L Pugh; Wolfgang A Tome; Chip Caine; Ben Corn; Andrew Kanner; Howard Rowley; Vijayananda Kundapur; Albert DeNittis; Jeffrey N Greenspoon; Andre A Konski; Glenn S Bauman; Sunjay Shah; Wenyin Shi; Merideth Wendland; Lisa Kachnic; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

4.  Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.

Authors:  Sonam Sharma; Matthew T McMillan; Abigail Doucette; Roger B Cohen; Abigail Berman; William Levin; Charles B Simone; Jacob Shabason
Journal:  Clin Lung Cancer       Date:  2017-12-14       Impact factor: 4.785

5.  A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.

Authors:  Chengcheng Gui; Namrata Chintalapati; Russell Kenneth Hales; Khinh Ranh Voong; Haris Iqbal Sair; Jimm Grimm; Mario Duhon; Lawrence Richard Kleinberg; Tracy Dawn Vannorsdall; Kristin Janson Redmond
Journal:  J Neurooncol       Date:  2019-07-13       Impact factor: 4.130

6.  Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.

Authors:  Aaron H Wolfson; Kyounghwa Bae; Ritsuko Komaki; Christina Meyers; Benjamin Movsas; Cecile Le Pechoux; Maria Werner-Wasik; Gregory M M Videtic; Yolanda I Garces; Hak Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-26       Impact factor: 7.038

7.  Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.

Authors:  Núria Rodríguez de Dios; Felipe Couñago; Mauricio Murcia-Mejía; Mikel Rico-Oses; Patricia Calvo-Crespo; Pilar Samper; Carmen Vallejo; Javier Luna; Itziar Trueba; Amalia Sotoca; Cristina Cigarral; Núria Farré; Rosa M Manero; Xavier Durán; Juan Domigo Gispert; Gonzalo Sánchez-Benavides; Teresa Rognoni; Margarita Torrente; Jaume Capellades; Mar Jiménez; Teresa Cabada; Miguel Blanco; Ana Alonso; Juan Martínez-San Millán; José Escribano; Beatriz González; José Luis López-Guerra
Journal:  J Clin Oncol       Date:  2021-08-11       Impact factor: 44.544

8.  Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.

Authors:  Andrew Bang; Wayne S Kendal; Scott A Laurie; Graham Cook; Robert M MacRae
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-01       Impact factor: 7.038

9.  Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.

Authors:  Vijayananda Kundapur; Tasha Ellchuk; Shahid Ahmed; Vinai Gondi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-15       Impact factor: 7.038

10.  Prophylactic cranial irradiation in extensive small-cell lung cancer.

Authors:  Ben Slotman; Corinne Faivre-Finn; Gijs Kramer; Elaine Rankin; Michael Snee; Matthew Hatton; Pieter Postmus; Laurence Collette; Elena Musat; Suresh Senan
Journal:  N Engl J Med       Date:  2007-08-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.